References
- Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?. Haematologica 2004; 89: 611–613
- Hayette S, Tigaud I, Thomas X, French M, Perrin M C, Nicoloni F, et al. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report. Leukemia 2004; 89: 1–2
- Demehri S, Paschka P, Schultheis B, Lange T, Koizumi T, Sugimoto T, et al. e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?. Leukemia 2005; 89: 1–4
- Verstovsek S, Lin H, Kantarijan H, Saglio G, De Micheli D, Pane F, et al. Neutrophilic-chronic myeloid leukemia. Cancer 2002; 94: 2416–2425
- Liu L G, Tanaka H, Ito K, Kyo T, Ito T, Kimura A. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3. Am J Hematol 2003; 74: 268–272
- van Dongen J J, Macintyre E A, Gabert J A, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928
- Bekassy A N, Hermans J, Gorin N C, Gratwohl A. Granulocytis sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 17: 801–808
- Hochhaus A, Reiter A, Skladny H, Melo J V, Sick C, Berger U, et al. A novel BCR-ABL fusion gene (e6A2) in a patient with Philadelphi chromossome-negative chronic myelogenous leukemia. Blood 1996; 88: 2236–2240
- Dupont M, Jourdan E, Chiesa J. Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML. Leukemia 2000; 14: 2011–2012
- Schulthesis B, Wang L, Clark R E, Melo J V. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Leukemia 2003; 17: 2054–2055
- Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?. Haematology 2004; 89: 611–613
- Hayette S, Tigaud I, Thomas X, French M, Perrin M C, Nicolini F, Michallet M, Magaud J P. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report. Leukemia 2004; 18: 1735–1736
- Roti G, La Starza R, Gorello P, Gottardi E, Crescenzi B, Martelli M F, Mecucci C. e6a2 BCR/ABLl fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia. Haematologica 2005; 90: 1139–1141
- Popovici C, Cailleres S, David M, Lafage-Pochitaloff M, Sainty D, Mozziconacci M -J. E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib. Leuk Lymphoma 2005; 46: 1375–1377
- Staal-Viliare A, Latger-Cannard V, Rault J P, Didion J, Grégoire M J, Bologna S, Witz B, Jonveaux P, Lecompte T, Rio Y. A case of de novo acute basophilic leukaemia: diagnostic criteria and review of the literature. Ann Biol Clin (Paris) 2006; 64: 361–365